2025 is going to be a big year for AI adoption in pharma. By now ... Ultimately, AI at scale is where companies can gain a real competitive advantage.

We didn’t do it based on ‘now we go back to the lab and we do large-scale experiments and ... Still, some big pharmaceutical ...

In the world of pharmaceuticals, companies aim to operate under GMP guidelines — a set of production and manufacturing measures to assure standards for medicinal products. But too often ...

Understanding that scaling content creation at speed can be a challenge for emerging companies ... Read the How Emerging Pharma Can Launch and Scale Content Faster eBook from Veeva in full.

Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ... across disciplines to ...

The president rolled out a plan that was less aggressive than his first-term effort in 2020, surprising analysts who were bracing for something tougher.

pharmaceutical companies in expediting market approval and trial time. This partnership aims to address the challenges in supply chain, compliance and regulatory affairs during product development.

For global pharma companies seeking growth and health equity, India offers a rare convergence of scale, diversity ... The Vision Pharma 2047 10 initiative aims to position India as a global leader in ...

The investment is aimed at supporting the company's strategy to deliver its platform and product suite to global pharma companies through a SaaS model, while continuing to invest in further ...

NEW YORK, July 24 (Reuters) - Big pharmaceutical companies that make personalized blood cancer treatments are working to cut the manufacturing turnaround time by as much as half in coming years ...